Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Study Number: URCC 16070
Study Summary:
This randomized phase III trial studies how well netupitant/palonosetron hydrochloride and dexamethasone with prochlorperazine or olanzapine work compared to netupitant/palonosetron hydrochloride and dexamethasone in improving chemotherapy-induced nausea and vomiting in patients with breast cancer. Antiemetic drugs, such as prochlorperazine and olanzapine, may help lessen nausea and vomiting in patients with breast cancer treated with chemotherapy.
Status: Open
Study Coordinator(s)
- Courtney, 309-243-3660 cbrown@illinoiscancercare.com
- Kelsey, 309-243-3618 kfay@illinoiscancercare.com
- Erica, 309-243-3626 eraynor@illinoiscancercare.com
